Since the outbreak of the epidemic caused by SARS-CoV-2, Clongene has taken swift actions and has successfully developed three kinds of COVID-19 detection reagents including antigen rapid test, antibody rapid test and nucleic acid test, which have continued to provide support for more than 100 countries around the world to fight the epidemic.
Clungene COVID-19 detection reagents have obtained the CE certification in EU, the TGA certification in Australia and some certifications from different countries, which demonstrate the quality of our products are approved by related government institutions.
For the semi-quantitative detection of IgG antibody to the SARS-CoV-2 virus in human venous whole blood, serum, plasma and fingerstick whole blood.
For qualitative detection of neutralizing antibodies to SARS-CoV-2 in human venous whole blood, serum, plasma and fingerstick whole blood.
For qualitative detection of IgG and IgM antibodies to the SARS-CoV-2 virus in whole blood, serum or plasma specimens from individuals.
For qualitative detection of neutralizing antibodies to SARS-CoV-2 in human whole blood, serum and plasma.
